The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective

Trends in Neurosciences

Volumn 39, Issue 4, 2016, Pages 221-234

  Martini Stoica, Heidi ^a   Xu, Yin ^a   Ballabio, Andrea ^a,b,c   Zheng, Hui ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autophagy lysosomal pathway; Neurodegenerative disease; Prion disease; TFEB

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EB; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; TFEB PROTEIN, HUMAN;

AUTOPHAGY; HUMAN; HUNTINGTON CHOREA; LYSOSOME; MACROAUTOPHAGY; NERVE DEGENERATION; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TAUOPATHY; ANIMAL; BRAIN; DEGENERATIVE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRAIN; HUMANS; LYSOSOMES; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES;

EID: 84959904698     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2016.02.002     Document Type: Review

References (125)

1. Sardiello M., et al. A gene network regulating lysosomal biogenesis and function. Science 2009, 325:473-477.
2. Settembre C., et al. TFEB links autophagy to lysosomal biogenesis. Science 2011, 332:1429-1433.
3. Komatsu M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
4. Hara T., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
5. Menzies F.M., et al. Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 2015, 16:345-357.
6. Yamamoto A., Simonsen A. The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol. Dis. 2011, 43:17-28.
7. Tsunemi T., et al. PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci. Transl. Med. 2012, 4:142ra197.
8. Decressac M., et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E1817-E1826.
9. Xiao Q., et al. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis. J. Neurosci. 2014, 34:9607-9620.
10. Polito V.A., et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol. Med. 2014, 6:1142-1160.
11. Xiao Q., et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Abeta generation and amyloid plaque pathogenesis. J. Neurosci. 2015, 35:12137-12151.
12. Medina D.L., et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell 2011, 21:421-430.
13. Cortes C.J., et al. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 2014, 17:1180-1189.
14. Spampanato C., et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol. Med. 2013, 5:691-706.
15. Song W., et al. TFEB regulates lysosomal proteostasis. Hum. Mol. Genet. 2013, 22:1994-2009.
16. Mizushima N., et al. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 2011, 27:107-132.
17. Hamasaki M., et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013, 495:389-393.
18. Ravikumar B., et al. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat. Cell Biol. 2010, 12:747-757.
19. Hailey D.W., et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010, 141:656-667.
20. Geng J., Klionsky D.J. The Golgi as a potential membrane source for autophagy. Autophagy 2010, 6:950-951.
21. Lamark T., Johansen T. Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 2012:736905.
22. Wang K., Klionsky D.J. Mitochondria removal by autophagy. Autophagy 2011, 7:297-300.
23. Rogov V., et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 2014, 53:167-178.
24. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
25. Lazarou M., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 2015, 524:309-314.
26. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22:407-417.
27. Kawamura N., et al. Delivery of endosomes to lysosomes via microautophagy in the visceral endoderm of mouse embryos. Nat. Commun. 2012, 3:1071.
28. Sahu R., et al. Microautophagy of cytosolic proteins by late endosomes. Dev. Cell 2011, 20:131-139.
29. Rehli M., et al. Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveal a common gene organization for all MiT subfamily members. Genomics 1999, 56:111-120.
30. Kuiper R.P., et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum. Mol. Genet. 2003, 12:1661-1669.
31. Palmieri M., et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 2011, 20:3852-3866.
32. Settembre C., et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012, 31:1095-1108.
33. Martina J.A., et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 2012, 8:903-914.
34. Roczniak-Ferguson A., et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 2012, 5:ra42.
35. Pena-Llopis S., et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 2011, 30:3242-3258.
36. Sancak Y., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
37. +-ATPase. Science 2011, 334:678-683.
38. Settembre C., et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 2013, 15:647-658.
39. Medina D.L., et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 2015, 17:288-299.
40. Rui Y.N., et al. Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 2015, 17:262-275.
41. Ochaba J., et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:16889-16894.
42. Martinez-Vicente M., et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 2010, 13:567-576.
43. Thompson L.M., et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 2009, 187:1083-1099.
44. Qi L., et al. The role of chaperone-mediated autophagy in huntingtin degradation. PLoS ONE 2012, 7:e46834.
45. Shibata M., et al. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J. Biol. Chem. 2006, 281:14474-14485.
46. Ravikumar B., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36:585-595.
47. Rose C., et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum. Mol. Genet. 2010, 19:2144-2153.
48. Tanaka M., et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 2004, 10:148-154.
49. Winslow A.R., et al. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 2010, 190:1023-1037.
50. Yang Q., et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323:124-127.
51. Gan-Or Z., et al. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008, 70:2277-2283.
52. Gan-Or Z., et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease. Neurology 2013, 80:1606-1610.
53. Mazzulli J.R., et al. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
54. Sardi S.P., et al. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12101-12106.
55. Sardi S.P., et al. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:3537-3542.
56. Dehay B., et al. Pathogenic lysosomal depletion in Parkinson's disease. J. Neurosci. 2010, 30:12535-12544.
57. Kilpatrick K., et al. Genetic and chemical activation of TFEB mediates clearance of aggregated alpha-synuclein. PLoS ONE 2015, 10:e0120819.
58. Song W., et al. 2-Hydroxypropyl-beta-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J. Biol. Chem. 2014, 289:10211-10222.
59. Pickrell A.M., Youle R.J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 2015, 85:257-273.
60. Hertz N.T., et al. A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1. Cell 2013, 154:737-747.
61. Nezich C.L., et al. MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J. Cell Biol. 2015, 210:435-450.
62. Siddiqui A., et al. Mitochondrial quality control via the PGC1alpha-TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin. J. Neurosci. 2015, 35:12833-12844.
63. Lee J.H., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
64. 2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 2015, 12:1430-1444.
65. Coen K., et al. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 2012, 198:23-35.
66. Nixon R.A., et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005, 64:113-122.
67. Pickford F., et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 2008, 118:2190-2199.
68. Rohn T.T., et al. Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer's disease brain. Neurobiol. Dis. 2011, 43:68-78.
69. Yang D.S., et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 2011, 134:258-277.
70. Wang Y., et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 2009, 18:4153-4170.
71. Kruger U., et al. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol. Aging 2012, 33:2291-2305.
72. Schaeffer V., et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012, 135:2169-2177.
73. Caccamo A., et al. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. Aging Cell 2013, 12:370-380.
74. Ozcelik S., et al. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. PLoS ONE 2013, 8:e62459.
75. Parr C., et al. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-beta precursor protein. Mol. Cell. Biol. 2012, 32:4410-4418.
76. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18:297-300.
77. Tiribuzi R., et al. miR128 up-regulation correlates with impaired amyloid beta(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol. Aging 2014, 35:345-356.
78. Coffey E.E., et al. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 2014, 263:111-124.
79. Zhang X., et al. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 2012, 32:8633-8648.
80. Landel V., et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol. Neurodegener. 2014, 9:33.
81. Aguzzi A., Sigurdson C.J. Antiprion immunotherapy: to suppress or to stimulate?. Nat. Rev. Immunol. 2004, 4:725-736.
82. Stohr J., et al. Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:11025-11030.
83. Sanders D.W., et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 2014, 82:1271-1288.
84. Iba M., et al. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J. Neurosci. 2013, 33:1024-1037.
85. Clavaguera F., et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 2009, 11:909-913.
86. Luk K.C., et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
87. Jaunmuktane Z., et al. Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 2015, 525:247-250.
88. Xu Y., et al. Activation of the macroautophagic system in scrapie-infected experimental animals and human genetic prion diseases. Autophagy 2012, 8:1604-1620.
89. Joshi-Barr S., et al. De novo prion aggregates trigger autophagy in skeletal muscle. J. Virol. 2014, 88:2071-2082.
90. Cortes C.J., et al. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Straussler-Scheinker disease. J. Neurosci. 2012, 32:12396-12405.
91. Aguib Y., et al. Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 2009, 5:361-369.
92. Doh-Ura K., et al. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 2000, 74:4894-4897.
93. Geschwind M.D., et al. Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology 2013, 81:2015-2023.
94. Castilla J., et al. In vitro generation of infectious scrapie prions. Cell 2005, 121:195-206.
95. Wischik C.M., et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:4506-4510.
96. Michell A.W., et al. The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease. Cell Transplant. 2007, 16:461-474.
97. Caughey B., et al. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol. 1991, 65:6597-6603.
98. Yu W.H., et al. Macroautophagy - a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 2005, 171:87-98.
99. Sevlever D., et al. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 2008, 47:9678-9687.
100. Tsujimura A., et al. Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils. Neurobiol. Dis. 2014, 73C:244-253.
101. Perera R.M., et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 2015, 524:361-365.
102. Jung C.H., et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20:1992-2003.
103. Fan W., et al. Autophagosome targeting and membrane curvature sensing by Barkor/Atg14(L). Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7769-7774.
104. Pattingre S., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
105. Obara K., Ohsumi Y. Dynamics and function of PtdIns(3)P in autophagy. Autophagy 2008, 4:952-954.
106. Shao Y., et al. Stimulation of ATG12-ATG5 conjugation by ribonucleic acid. Autophagy 2007, 3:10-16.
107. Fujioka Y., et al. Dimeric coiled-coil structure of Saccharomyces cerevisiae Atg16 and its functional significance in autophagy. J. Biol. Chem. 2010, 285:1508-1515.
108. Satoo K., et al. The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J. 2009, 28:1341-1350.
109. Metlagel Z., et al. Structural insights into E2-E3 interaction for LC3 lipidation. Autophagy 2014, 10:522-523.
110. Nath S., et al. Lipidation of the LC3/GABARAP family of autophagy proteins relies on a membrane-curvature-sensing domain in Atg3. Nat. Cell Biol. 2014, 16:415-424.
111. Ravikumar B., et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 2005, 37:771-776.
112. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 1998, 279:519-526.
113. Itakura E., et al. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012, 151:1256-1269.
114. Zoncu R., et al. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011, 12:21-35.
115. Jewell J.L., et al. Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 2013, 14:133-139.
116. Bar-Peled L., et al. Ragulator is a GEF for the Rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208.
117. Lamming D.W., et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012, 335:1638-1643.
118. Mammucari C., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6:458-471.
119. Tzivion G., et al. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 2011, 1813:1938-1945.
120. Arias E., et al. Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy. Mol. Cell 2015, 59:270-284.
121. Hemesath T.J., et al. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 1994, 8:2770-2780.
122. Pogenberg V., et al. Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF. Genes Dev. 2012, 26:2647-2658.
123. Martina J.A., et al. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci. Signal. 2014, 7:ra9.
124. Ploper D., et al. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E420-E429.
125. Zhang Y., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 2014, 34:11929-11947.